Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Karo Bio Plans To Net SEK120M From Discounted Rights Issue

April 16, 2003

By Cormac Sheridan

Affitech, NatImmune Team Up In Colon Cancer Collaboration

April 16, 2003

By Cormac Sheridan

Affitech, NatImmune Team Up In Colon Cancer Collaboration

April 16, 2003

By Cormac Sheridan

Karo Bio Plans To Net SEK120M From Discounted Rights Issue

April 16, 2003

By Cormac Sheridan

Galapagos Enters Collaboration In Nutraceuticals With Degussa

April 9, 2003

By Cormac Sheridan

GeneProt Slashes Staff, Cites Current Economic Environment

April 9, 2003

By Cormac Sheridan

Galapagos Enters Collaboration In Nutraceuticals With Degussa

April 9, 2003

By Cormac Sheridan

BioXell Moves BXL-628 Into Phase II Clinical Trial For BPH

April 2, 2003

By Cormac Sheridan

Irish Delegation Visiting NIH To Seek Licensing Opportunities

April 2, 2003

By Cormac Sheridan

Zealand Completes Funding, Seeks New ZP10 Partnership

April 2, 2003

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...